Patrick Pétrossians

Prof. Patrick Pétrossians


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2020 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
ECEva C Coopmans
Eva C Coopmans
TKTim I M Korevaar
Tim I M Korevaar
SMSebastiaan W F van Meyel
Sebastiaan W F van Meyel
ADAdrian F Daly
Adrian F Daly
PCPhilippe Chanson
Philippe Chanson
SNSebastian J C M M Neggers
Sebastian J C M M Neggers
Context First-generation somatostatin receptor ligands (fg-SRLs) represent the mainstay of medical therapy for acromegaly, but they provide biochemical control of disease in only a subset of patients. Various pretreatment biomarkers might affect biochemical response to fg-SRLs. Objective To identify clinical predictors of the biochemical response to fg-SRLs monotherapy defined as biochemical response (insulin-like growth factor (IGF)-1 ≤ 1.3 × ULN (upper limit of normal)), partial response (>20% relative IGF-1 reduction without normalization), and nonresponse (≤20% relative IGF-1 reduction), and IGF-1 reduction. Design Retrospective multicenter study. Setting Eight participating European centers. Methods We performed a meta-analysis of participant data from 2 cohorts (Rotterdam and Liège acromegaly survey, 622 out of 3520 patients). Multivariable regression models were used to identify predictors of biochemical response to fg-SRL monotherapy. Results Lower IGF-1 concentration at baseline (odds ratio (OR) = 0.82, 95% confidence interval (CI) 0.72–0.95 IGF-1 ULN, P = .0073) and lower bodyweight (OR = 0.99, 95% CI 0.98–0.99 kg, P = .038) were associated with biochemical response. Higher IGF-1 concentration at baseline (OR = 1.40, (1.19–1.65) IGF-1 ULN, P ≤ .0001), the presence of type 2 diabetes (oral medication OR = 2.48, (1.43–4.29), P = .0013; insulin therapy OR = 2.65, (1.02–6.70), P = .045), and higher bodyweight (OR = 1.02, (1.01–1.04) kg, P = .0023) were associated with achieving partial response. Younger patients at diagnosis are more likely to achieve nonresponse (OR = 0.96, (0.94–0.99) year, P = .0070). Baseline IGF-1 and growth hormone concentration at diagnosis were associated with absolute IGF-1 reduction (β = 0.90, standard error (SE) = 0.02, P ≤ .0001 and β = 0.002, SE = 0.001, P = .014, respectively). Conclusion Baseline IGF-1 concentration was the best predictor of biochemical response to fg-SRL, followed by bodyweight, while younger patients were more likely to achieve nonresponse.

28 January 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
IPIulia Potorac
Iulia Potorac
MLMarie Laterre
Marie Laterre
OMOlivier Malaise
Olivier Malaise
VNVlad Nechifor
Vlad Nechifor
CFCorinne Fasquelle
Corinne Fasquelle
APAxelle Pintiaux
Axelle Pintiaux
Infertility in couples is a common problem, with both female and male factors contributing to similar extents. Severe, congenital disorders affecting fertility are, however, rare. While folliculogenesis and spermatogenesis are generally orchestrated via different mechanisms, some genetic anomalies can impair both female and male gametogenesis. Minichromosome maintenance complex component 9 (MCM9) is involved in DNA repair and mutations of the MCM9 gene have been previously reported in females with premature ovarian insufficiency (POI). MCM9 is also an emerging cancer risk gene. We performed next-generation and Sanger sequencing of fertility and related genes and hormonal and imaging studies in a kindred whose members had POI and disordered spermatogenesis. We identified a homozygous pathogenic MCM9 variant, c.394C>T (p.Arg132*) in three sisters affected by POI due to ovarian dysgenesis and their brother who had normal pubertal development but suffered from non-obstructive azoospermia. Testicular biopsy revealed Sertoli cell-only testicular histopathology. No evidence of early onset cancer was found in the homozygotic family members, but they were all young (<30 years) at the time of the study. In the male patient the homozygous MCM9 variant led to normal pubertal development and hormonal levels but caused a Sertoli-cell-only syndrome with non-obstructive azoospermia. In the homozygous females studied, the clinical, hormonal, and gonadal phenotypes revealed ovarian dysgenesis consistent with previous reports. Active screening for potential colorectal and other cancer risks in the homozygotic MCM9 subjects has been instigated.

28 April 2023 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
Justine EppeJustine Eppe
Justine Eppe
PPPatrick Pétrossians
Patrick Pétrossians
VBValeria Busoni
Valeria Busoni
FRFrédéric Rollin
Frédéric Rollin
HGHugues Guyot
Hugues Guyot
Little is known about thyroid diseases in ruminants, probably due to the lack of diagnosis techniques developed in this species. However, thyroid ultrasound (TU) is widely used in human and in companion animal’s medicine. It is a cheap and non-invasive examination, which allows for the identification of thyroid structures or diffuse diseases. The aim of this study was to evaluate the accuracy of TU in five calves and five cows through inter- and intra-observer repeatability. The size of the thyroid gland was measured from three views: left sagittal, right sagittal and transverse; nine measurements per view. The intra-observer coefficient was calculated for each observer. For the inter-observer, the first observer was a board-certified imagist (European College of Veterinary Diagnostic Imaging diplomate), the second was a board-certified specialist in bovine and herd management (European College of Bovine Health Managementdiplomate) and the third was an in-trained veterinarian for the TU. They each scanned the thyroid gland successively, following the same method. The intra-observer variabilities for observers 1, 2 and 3 were 8.22%, 5.53%, 5.38%, and 7.18%, 8.65% and 6.36%, respectively, for calves and cows. The inter-observer variability for calves was 10.4% and for cows, 11.8%. This study confirms the feasibility of repeatable intra- and inter-observer TU-estimated measurements in cattle.

3 November 2025 in Reports
Verified
Journal Article
Open access
PDF file
MSMarine Sluys
Marine Sluys
PDPauline Delannoy
Pauline Delannoy
LLLaurence Lousberg
Laurence Lousberg
MSMarie Strivay
Marie Strivay
ADAdrian Daly
Adrian Daly
PPPatrick Pétrossians
Patrick Pétrossians
Background and Clinical Significance: Ectopic ACTH secretion is a rare, potentially life-threatening cause of Cushing’s syndrome that can be overlooked when small neuroendocrine tumors evade standard imaging. Case Presentation: A 34-year-old woman presented with rapidly progressing clinical signs/symptoms of Cushing’s syndrome and demonstrated marked hypercortisolism (cortisol 2428 nmol/L; ACTH 163 ng/mL; urinary free cortisol 815 μg/24 h; K+ 2.4 mmol/L). Small hypermetabolic nodules were noted in her right lung on 18F-FDG PET/CT but were initially deemed to be infectious; DOTANOC PET-CT and inferior petrosal sinus sampling were non-diagnostic. After medically induced inhibition of cortisol, repeat PET/CT showed a persistent 13 mm lung nodule. Biopsy confirmed a well-differentiated pulmonary carcinoid (Ki-67 3%), and lobectomy achieved biochemical remission. Conclusions: Diagnostic delay stemmed from human factors despite early suggestive imaging. Ectopic ACTH secretion should remain high on the differential diagnosis in rapidly evolving, severe ACTH-dependent Cushing’s disease; early, decisive diagnosis and coordinated care overseen by endocrinologists—preferably in expert centers—can shorten exposure to deleteriously high cortisol levels and improve outcomes.